Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025)

Prestige Consumer Healthcare (PBH) recorded quarterly Non Operating Income of -$10.0 million in Q4 2025, up 5.05% quarter-over-quarter from -$10.5 million in Q3 2025, and down 2734.28% on a YoY basis from $379800.5 in Q4 2024.

Prestige Consumer Healthcare (PBH) Non Operating Income (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Non Operating Income history runs 16 years deep, the most recent figure standing at -$10.0 million for Q4 2025.

  • In Q4 2025, Non Operating Income fell 2734.28% year-over-year to -$10.0 million; the TTM figure through Dec 2025 stood at -$24.0 million (up 74.27% YoY), while the FY2025 annual figure was -$5.0 million, up 92.54% from the prior year.
  • Non Operating Income was -$10.0 million for Q4 2025 at Prestige Consumer Healthcare, up from -$10.5 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $49.9 million in Q1 2022 to a low of -$68.7 million in Q1 2023.
  • Historically, Non Operating Income has averaged -$12.7 million across 5 years, with a median of -$11.6 million in 2024.
  • Biggest YoY gain for Non Operating Income was 263.42% in 2022; the steepest drop was 15449.52% in 2022.
  • A 5-year view of Non Operating Income shows it stood at -$17.1 million in 2021, then decreased by 11.5% to -$19.1 million in 2022, then surged by 96.42% to -$682000.0 in 2023, then soared by 48.24% to -$353000.0 in 2024, then slumped by 2734.28% to -$10.0 million in 2025.
  • The last three Non Operating Income figures came in at -$10.0 million (Q4 2025), -$10.5 million (Q3 2025), and $224000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn -216.00 Mn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 20.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -7.50 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 53.40 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -34,272.67
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn -
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn -13.65 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 5.71 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn -4.72 Mn
10 Prestige Consumer Healthcare 2.34 Bn 2.27 Bn 157.37 Mn -10.01 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -10.01 Mn
Sep 30, 2025 -10.54 Mn
Jun 30, 2025 224,000.00
Mar 31, 2025 -3.71 Mn
Dec 31, 2024 -353,000.00
Sep 30, 2024 -12.68 Mn
Jun 30, 2024 -13.63 Mn
Mar 31, 2024 -66.73 Mn
Dec 31, 2023 -682,000.00
Sep 30, 2023 -17.84 Mn
Jun 30, 2023 1.24 Mn
Mar 31, 2023 -68.71 Mn
Dec 31, 2022 -19.07 Mn
Sep 30, 2022 -17.79 Mn
Jun 30, 2022 -16.12 Mn
Mar 31, 2022 49.95 Mn
Dec 31, 2021 -17.10 Mn
Sep 30, 2021 -493,000.00
Jun 30, 2021 105,000.00
Mar 31, 2021 -30.56 Mn